Skip to content
Catalyst

biphenylWhat was measured

Measured, with no finding

72 endpoints

Show what was measuredHide what was measured
  • PCB reference values in human blood

    The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L

    PMID 15134393 · one of two readings recorded this

  • PCB reference values in human blood

    The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L

    PMID 15134393 · one of two readings recorded this

  • PCB reference values in human blood

    The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L

    PMID 15134393 · one of two readings recorded this

  • reference values for blood PCB concentration

    1.2-8.28 microg/L (males); 2.69-5.17 microg/L (females); overall range 0.9-56 microg/L

    The PCBs RVs resulted between 1.2 e 8.28 microg/L for males and between 2.69 e 5.17 microg/L for females the general range varied from 0.9 to 56 microg/L.

    PMID 15134393 · one of two readings recorded this

  • carcinogenicity and noncancer health hazards of oral biphenyl exposure (male rat urinary bladder tumors, female mouse liver tumors, kidney toxicity), narrative synthesis of experimental animal bioassays and mechanistic studies for EPA IRIS

    increases

    Not recorded as a finding: a review that discusses its trials without pooling them

    The available health effects data for biphenyl provides suggestive evidence for carcinogenicity in humans, based on increased incidences of male rat urinary bladder tumors at high exposure levels and on female mouse liver tumors.

    PMID 26529796 · one of two readings recorded this

  • Carcinogenicity (male rat urinary bladder tumors, female mouse liver tumors) and kidney toxicity from oral biphenyl exposure, reviewed across experimental animal bioassays and mechanistic studies

    increases

    Not recorded as a finding: a review that discusses its trials without pooling them

    The available health effects data for biphenyl provides suggestive evidence for carcinogenicity in humans, based on increased incidences of male rat urinary bladder tumors at high exposure levels and on female mouse liver tumors.

    PMID 26529796 · one of two readings recorded this

  • liver tumor incidence (hepatocellular adenoma/carcinoma), female BDF1 mice

    increases

    Exposure to biphenyl in the diet for 2 years was associated with a statistically significant dose-related increase in the incidence of liver tumors (hepatocellular adenomas or carcinomas) in female BDF1 mice (Table 3).

    PMID 26529796 · one of two readings recorded this

  • renal toxicity (mineralization, necrosis, hyperplasia)

    increases

    Kidney toxicity is also a potential human health hazard of biphenyl exposure.

    PMID 26529796 · one of two readings recorded this

  • urinary bladder tumor incidence (transitional cell papilloma/carcinoma), male F344 rats

    increases, 31/50 papilloma or carcinoma combined at high dose vs 0/50 controls, n = 50

    A dose-related increase in transitional cell papilloma and carcinoma of the urinary bladder was reported in male F344 rats exposed to biphenyl in the diet for 2 years (Table 2).

    PMID 26529796 · one of two readings recorded this

  • breast cancer risk, Group II and Group III PCB congeners

    increases, OR = 1.23 (95% CI 1.08-1.40) for Group II; OR = 1.25 (95% CI 1.09-1.43) for Group III

    The pooled ORs were 1.23 (95%CI: 1.08–1.40) for group II and 1.25 (95%CI: 1.09–1.43) for group III, respectively.

    PMID 26555153 · one of two readings recorded this

  • breast cancer risk, total PCB exposure (highest vs lowest category)

    no effect, OR = 1.09 (95% CI: 0.97-1.22)

    Overall, the summary OR of total PCBs was slightly elevated but not statistically significant and heterogeneity was relatively high (OR = 1.09, 95%CI: 0.97–1.22, I2 = 55.4%).

    PMID 26555153 · one of two readings recorded this

  • anti-fungal activity

    increases, Some of the compounds have shown significant pharmacological properties.

    Some of the compounds have shown significant pharmacological properties.

    PMID 28083853 · both readings recorded this

  • anti-HIV-1 reverse transcriptase inhibition activity

    Anti-HIV activity using anti-HIV-1 reverse transcriptase and syncytium inhibition assays, and cytotoxic activity against a panel of cultured mammalian cancer cell lines of isolated compounds were investigated.

    PMID 29247893 · one of two readings recorded this

  • cytotoxic activity against cultured mammalian cancer cell lines

    Anti-HIV activity using anti-HIV-1 reverse transcriptase and syncytium inhibition assays, and cytotoxic activity against a panel of cultured mammalian cancer cell lines of isolated compounds were investigated.

    PMID 29247893 · one of two readings recorded this

  • urinary estrone-3-glucuronide, pregnanediol-3-glucuronide and FSH levels across the menstrual cycle

    decreases, n = 70

    We observed that high (>3.0 parts per billion [ppb]) and medium (>1.0-3.0 ppb) PBB exposure were associated with lower E13G levels across the menstrual cycle and lower FSH levels during the follicular phase, compared with low PBB exposure (≤1.0 ppb).

    PMID 31180930 · one of two readings recorded this

  • urinary reproductive hormone levels (estrone-3-glucuronide, pregnanediol-3-glucuronide, FSH) across the menstrual cycle

    decreases, n = 70

    Not recorded as a finding: the trial gave a chemically different species

    We observed that high (>3.0 parts per billion [ppb]) and medium (>1.0-3.0 ppb) PBB exposure were associated with lower E13G levels across the menstrual cycle and lower FSH levels during the follicular phase, compared with low PBB exposure (≤1.0 ppb).

    PMID 31180930 · one of two readings recorded this

  • Association between polychlorinated biphenyl exposure and breast cancer risk, reviewed across epidemiologic studies

    no effect

    Not recorded as a finding: the trial gave a chemically different species

    However, the results of most epidemiologic studies do not support an association between PCB exposure and breast cancer risk.

    PMID 31521536 · one of two readings recorded this

  • breast cancer risk

    no effect

    However, the results of most epidemiologic studies do not support an association between PCB exposure and breast cancer risk.

    PMID 31521536 · one of two readings recorded this

  • cardiac output

    increases

    In vivo, compound 15a demonstrated a dose-dependent improvement in the cardiac output in male Sprague Dawley rats with no significant changes in either mean arterial blood pressure or heart rate

    PMID 31724863 · one of two readings recorded this

  • in vitro APJ receptor potency

    no effect

    Compound 15a demonstrated comparable in vitro potency to apelin-13, the endogenous peptidic ligand for the APJ receptor

    PMID 31724863 · one of two readings recorded this

  • mean arterial blood pressure and heart rate

    no effect

    In vivo, compound 15a demonstrated a dose-dependent improvement in the cardiac output in male Sprague Dawley rats with no significant changes in either mean arterial blood pressure or heart rate

    PMID 31724863 · one of two readings recorded this

  • offspring birthweight (lowest quartile) and gestational age by paternal PBB/PCB tertile

    increases, aRR = 2.06 (95% CI: 1.12, 3.79), upper paternal PBB tertile vs lower tertile, n = 336

    Not recorded as a finding: the trial gave a chemically different species

    Lowest quartile offspring birthweight was associated with monotonic increased adjusted risk ratios (aRR) in the middle (aRR=1.67, 95% CI: 0.93, 2.99) and upper tertiles (aRR=2.06, 95% CI = 1.12, 3.79) for PBB (Table 3).

    PMID 36041536 · one of two readings recorded this

  • offspring birthweight, lowest quartile

    increases, aRR = 1.67 (95% CI: 0.93, 2.99) middle tertile; aRR = 2.06 (95% CI: 1.12, 3.79) upper tertile, paternal PBB, n = 336

    Lowest quartile offspring birthweight was associated with monotonic increased adjusted risk ratios (aRR) in the middle (aRR=1.67, 95% CI: 0.93, 2.99) and upper tertiles (aRR=2.06, 95% CI = 1.12, 3.79) for PBB (Table 3).

    PMID 36041536 · one of two readings recorded this

  • offspring preterm birth / gestational age

    no effect

    Preterm gestational age was not associated with increasing paternal PBB or PCB levels in the log-risk models (Table 4).

    PMID 36041536 · one of two readings recorded this

  • semen quality decline, evidence rating

    decreases

    We found robust evidence that PCB-118 and -169 were linked to declines in semen quality

    PMID 36217156 · one of two readings recorded this

  • semen quality decline, evidence rating

    decreases

    Evidence for adverse effects of PCB-126, -132, -149, and -153 was moderate, whereas for PCB-77 it was slight and for PCB-180 indeterminate

    PMID 36217156 · one of two readings recorded this

  • semen quality in experimental animal studies

    decreases

    Our review of experimental animal studies found that treatments with PCBs affected semen quality, in most cases adversely

    PMID 36217156 · one of two readings recorded this

  • high priority studies identified by DoCTER clustering and ML from 2015 search

    n = 11177

    Collectively, clustering and ML approaches using DoCTER identified 11,177 studies from the initial literature search conducted in 2015 as high priority studies for manual review

    PMID 36580985 · one of two readings recorded this

  • human and nonhuman mammalian studies evaluated for health endpoints

    n = 1590

    A total of 953 human studies and 637 nonhuman mammalian studies were evaluated for health endpoints and exposure to PCBs

    PMID 36580985 · one of two readings recorded this

  • human studies of PCB exposure and allergy or asthma

    n = 43

    Forty-three human studies evaluated PCB exposure in relation to allergy or asthma

    PMID 36580985 · one of two readings recorded this

  • male reproductive organ size/weight studies

    n = 72

    Male reproductive organ size/weight was measured in only eight human studies but 72 nonhuman mammalian studies

    PMID 36580985 · one of two readings recorded this

  • nonhuman mammalian studies of renal biomarkers

    n = 28

    Only four human studies evaluated frank renal disease or diabetic nephropathy; the majority instead measured biomarkers of renal function

    PMID 36580985 · one of two readings recorded this

  • proportion of nonprioritized studies relevant to PECO criteria

    Review of a randomly selected subset of nonprioritized studies demonstrated that less than 10% of nonprioritized studies were relevant based on PECO criteria

    PMID 36580985 · one of two readings recorded this

  • seed references designated from studies meeting PECO criteria

    n = 483

    Briefly, 483 studies selected as having met the PECO criteria for inclusion in this review (Table 1) were designated as seed references

    PMID 36580985 · one of two readings recorded this

  • studies added by yearly literature search updates 2016 to 2021

    n = 11390

    Yearly literature search updates were conducted from 2016 to 2021, yielding between 1756 and 2402 unique studies per year, which added 11,390 studies

    PMID 36580985 · one of two readings recorded this

  • studies identified by 2015 initial literature search after duplicate removal

    n = 50309

    After duplicate removal, 50,309 studies were identified from the initial literature search conducted in 2015

    PMID 36580985 · one of two readings recorded this

  • studies identified through database searching after duplicate removal, 2015-2021

    n = 61699

    Thus, 61,699 studies were identified through database searching after duplicate removal

    PMID 36580985 · one of two readings recorded this

  • studies included in literature summary tables

    n = 1586

    After full-text review and categorization, 1586 studies were included in literature summary tables organized by organ/system

    PMID 36580985 · one of two readings recorded this

  • studies manually reviewed in 2016 updates

    n = 1818

    In 2016, all 1818 unique studies were manually reviewed

    PMID 36580985 · one of two readings recorded this

  • studies manually reviewed (title and abstract) from database searches

    n = 17037

    Thus, 17,037 (27.6%) of the 61,699 studies retrieved through literature searches were manually reviewed

    PMID 36580985 · one of two readings recorded this

  • studies of response to immune challenge

    n = 28

    Response to immune challenge was evaluated in seven human studies (after vaccination) and 28 nonhuman mammalian studies

    PMID 36580985 · one of two readings recorded this

  • studies prioritized with SWIFT-Active Screener and manually screened from 2017-2021 retrieval

    n = 4042

    Of the 9572 studies retrieved in 2017–2021, 4042 studies were prioritized using SWIFT-Active Screener and were manually screened

    PMID 36580985 · one of two readings recorded this

  • studies subjected to full-text review

    n = 3889

    Of these, 3889 were identified as potentially relevant and subjected to full-text review and categorization by health endpoint

    PMID 36580985 · one of two readings recorded this

  • total studies in manual review including seed and expert-identified studies

    n = 17937

    The manual review thus included 17,937 studies

    PMID 36580985 · one of two readings recorded this

  • maximum response relative to orexin-A, OX1 receptor, most potent azulene-based compound

    The most potent azulene-based compound was identified as an OX1 orexin receptor agonist (pEC50 = 5.79 ± 0.07, maximum response = 81 ± 8% (s.e.m. of five independent experiments) of the maximum response to orexin-A in Ca2+ elevation assay)

    PMID 37209639 · one of two readings recorded this

  • articles reporting PCB half-lives in humans

    n = 26

    In total, 26 articles were found to report half-lives in humans, with the majority of data coming from studies performed in North America on individuals suspected to have been exposed to PCBs

    PMID 37832892 · one of two readings recorded this

  • PCB half-life by degree of chlorination

    decreases

    Less chlorinated PCBs generally have shorter half-lives than more chlorinated PCBs

    PMID 37832892 · one of two readings recorded this

  • PCB half-life, occupationally exposed versus general population

    decreases

    We also identified significantly shorter half-lives for some PCBs in occupationally exposed individuals compared to results reported from the general population

    PMID 37832892 · one of two readings recorded this

  • NLRP3 inflammasome inhibition (binding affinity, IC50) and anti-inflammatory activity in a mouse acute peritonitis model

    decreases, IC50 = 0.57 μM; KD = 1.15 μM

    Not recorded as a finding: the trial gave a chemically different species

    The representative compound H28 was identified as potent and specific NLRP3 inflammasome inhibitor with IC50 values of 0.57 μM.

    PMID 38492493 · one of two readings recorded this

  • NLRP3 inflammasome pathway activation, mouse acute peritonitis model

    decreases

    The results in a mouse acute peritonitis model revealed that H28 effectively inhibit the NLRP3 inflammasome pathway, demonstrating their anti-inflammatory properties.

    PMID 38492493 · one of two readings recorded this

  • NLRP3 inflammasome pathway inhibition in acute peritonitis

    decreases

    The results in a mouse acute peritonitis model revealed that H28 effectively inhibit the NLRP3 inflammasome pathway, demonstrating their anti-inflammatory properties.

    PMID 38492493 · one of two readings recorded this

  • NLRP3 protein binding (KD) and inflammasome assembly/activation inhibition by biphenyl-sulfonamide compound H28, in vitro and in a mouse acute peritonitis model

    decreases

    Not recorded as a finding: the trial gave a chemically different species

    Preliminary mechanistic studies have revealed that compound H28 exhibits direct binding to the NLRP3 protein (KD: 1.15 μM), effectively inhibiting the assembly and activation of the NLRP3 inflammasome.

    PMID 38492493 · one of two readings recorded this

  • diabetes mellitus

    increases, OR = 3.593 (95% CI 2.566, 5.031)

    The pooled OR showed that PCB congener exposure among the population was highly associated with the risk of DM (OR = 3.593, 95% CI 2.566, 5.031).

    PMID 39095444 · one of two readings recorded this

  • hypertension

    no effect, OR = 1.335 (95% CI 0.902, 1.976)

    However, the pooled OR showed a lack of association between PCB congener exposure and the risk of HTN (OR = 1.335, 95% CI 0.902, 1.976).

    PMID 39095444 · one of two readings recorded this

  • hypertriglyceridaemia

    no effect, OR = 1.611 (95% CI 0.981, 2.643)

    The pooled OR was 1.611 (95% CI 0.981, 2.643), suggesting no association between PCB congener exposure and the risk of HTG.

    PMID 39095444 · one of two readings recorded this

  • low HDL cholesterol

    decreases, OR = 0.34 (95% CI 0.092, 1.258)

    However, the pooled OR (0.34, 95% CI 0.092, 1.258) showed that there was a negative association between PCB congener exposure and the risk of having low HDL.

    PMID 39095444 · one of two readings recorded this

  • metabolic syndrome, dioxin exposure

    increases, OR = 2.742 (95% CI 1.936, 3.883)

    The pooled OR described minimal association (OR = 2.742, 95% CI 1.936, 3.883).

    PMID 39095444 · one of two readings recorded this

  • metabolic syndrome, PCB exposure

    no effect, OR = 1.162 (95% CI 0.994, 1.357)

    The pooled OR showed a limited association (OR = 1.162, 95% CI 0.994, 1.357) that was statistically insignificant (P > 0.05).

    PMID 39095444 · one of two readings recorded this

  • obesity (BMI > 30 kg/m2)

    no effect, OR = 1.875 (95% CI 0.883, 3.979)

    The pooled effects estimated from all three studies showed no statistical significance (P = 0.102, random effect) between the association of PCB congener exposure and an increase in BMI.

    PMID 39095444 · one of two readings recorded this

  • Ectopic lesion growth in a mouse endometriosis model and ERβ-mediated epigenetic regulation following PCB-126 exposure

    increases

    Not recorded as a finding: the trial gave a chemically different species

    In a mouse model of endometriosis, PCB-126 exposure significantly promoted the growth of ectopic lesions by activating the Steroid Receptor Coactivator-1 (SRC-1) isoform/Matrix Metalloproteinase-9 (MMP9)/Estrogen Receptor-β (ERβ) axis, a critical pathway driving disease progression.

    PMID 40951281 · one of two readings recorded this

  • endometriotic ectopic lesion volume and ERβ/AXL/GAS6/DNMT3A pathway activation in mouse and human endometriotic tissue

    increases

    Not recorded as a finding: the trial gave a chemically different species

    Compared to vehicle-treated mice, PCB126 exposure significantly increased the volume of ectopic lesions.

    PMID 40951281 · one of two readings recorded this

  • endometriotic ectopic lesion volume, AXL inhibitor effect

    decreases

    BMS-777607 treatment significantly reduced the volume of endometriotic lesions in PCB126-exposed mice compared to the vehicle-treated group (and).

    PMID 40951281 · one of two readings recorded this

  • endometriotic ectopic lesion volume

    increases

    Compared to vehicle-treated mice, PCB126 exposure significantly increased the volume of ectopic lesions.

    PMID 40951281 · one of two readings recorded this

  • pregnancy loss and birth defects

    unclear

    There were fewer human studies of pregnancy loss or birth defects, and the evidence was generally less consistent for these outcomes

    PMID 41702292 · one of two readings recorded this

  • relevant studies identified

    n = 154

    We identified n = 154 relevant studies, the majority of which focused on birth weight or other aspects of early life size and growth

    PMID 41702292 · one of two readings recorded this

  • size at birth

    decreases

    These studies often reported decrements in size at birth associated with higher maternal measures of exposure, although the evidence was less clear for size and growth in later childhood

    PMID 41702292 · one of two readings recorded this

  • Inhibition of LPS-induced nitric oxide release in BV2 microglial cells by six new biphenyl derivatives isolated from Garcinia yunnanensis

    decreases

    Not recorded as a finding: the trial gave a chemically different species

    Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.

    PMID 42055094 · one of two readings recorded this

  • LPS-induced nitric oxide (NO) release

    decreases

    Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.

    PMID 42055094 · one of two readings recorded this

  • LPS-induced nitric oxide release in BV2 microglial cells

    decreases

    Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.

    PMID 42055094 · one of two readings recorded this

  • LPS-induced nitric oxide release inhibition in BV2 microglial cells

    decreases

    Not recorded as a finding: the trial gave a chemically different species

    Additionally, all six new compounds were evaluated for their ability to inhibit LPS-induced nitric oxide (NO) release in BV2 microglial cells, demonstrating moderate anti-inflammatory activity.

    PMID 42055094 · one of two readings recorded this

  • blood/tissue PCB congener concentration after known exposure incidents vs general-population controls

    increases, 6.9 ppb (Yusho patients) vs 1.6 ppb (Fukuoka controls), n = 11

    Figure 1 graphically depicts mean PCB serum levels for the selected tetra through heptachlorinated PCBs in blood of 11 patients as compared to the control blood from the general population.

    PMID 8187704 · one of two readings recorded this

  • blood/tissue PCB congener concentrations in exposed cohorts (Yusho patients, Guam workers, firefighters, exposed children, Vietnam veterans) versus controls

    increases, 6.9 ppb (Yusho patients) vs 1.6 ppb (Fukuoka controls), n = 11

    Not recorded as a finding: the trial gave a chemically different species

    Figure 1 graphically depicts mean PCB serum levels for the selected tetra through heptachlorinated PCBs in blood of 11 patients as compared to the control blood from the general population.

    PMID 8187704 · one of two readings recorded this